The molecular biology of oral carcinogenesis: Toward a tumor progression model

Journal of Oral and Maxillofacial Surgery

Volumn 55, Issue 6, 1997, Pages 613-623

  Todd, Randy ^a,b   Donoff, R Bruce ^b   Wong, David T W ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; PROTEIN P53;

ARTICLE; CANCER GENETICS; GENE ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MOLECULAR BIOLOGY; MOUTH CANCER; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 0030926441     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-2391(97)90495-X     Document Type: Article

References (96)

1. Boring CC, Squires TS, Tong T: Cancer statistics, 1992. CA Cancer statistics, 1992. CA Cancer J Clin 42:19, 1992
2. Silverman SJ: Early diagnosis of oral cancer Cancer 62:1796, 1988
3. Vokes EE, Weichselbaum RR, Lippman SM, et al: Head and neck cancer. N Engl J Med 328:184, 1993
4. Sidransky D: Molecular genetics of head and neck cancer. Curr Opin Oncol 7:229, 1995
5. Silverman SJ, Gorsky M: Epidemiologic and demographic update in oral cancer: California and national data - 1973 to 1985. J Am Dent Assoc 120:495, 1990
6. Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 41:184, 1988
7. Schantz SP: Carcinogenesis, markers, staging, and prognosis of head and neck cancer. Curr Opin Oncol 5.483, 1993
8. Brandama JL, Abramson AL: Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg 115:621, 1989
9. Park NH, Li SL, Xie JF, et al: In vitro and animal studies of the role of viruses in oral carcinogenesis. Eur J Cancer B Oral Oncol 28B:45, 1992
10. Howley PM: Role of the human papillomavirus in human cancer. Cancer Res 51:5019, 1991
11. Scully C: Oncogenes, tumors suppressors and viruses in oral squamous carcinoma. J Oral Pathol Med 22:337, 1993
12. Lund VJ, Howard DJ: Head and neck cancer in the young: A prognostic conundrum? J Laryngol Otol 104:544, 1990
13. Shields SP, Harris CC: Molecular epidemiology and the genetics of environmental cancer. JAMA 266:681, 1991
14. Field JK: Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. Oral Oncol Eur J Cancer 28:67, 1992
15. Owens W, Field JK, Howard PJ, et al: Multiple cytogenetic aberrations squamous cell carcinomas of the head and neck. Oral Oncol Eur J Cancer 28:17, 1992
16. Vogelstein B, Kinzler KW: The multistep nature of cancer. Trends Genet 9:138, 1993
17. Renan MJ: How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinog 7:139, 1993
18. Bishop JM: Molecular themes in oncogenesis. Cell 64:235, 1991
19. Weiner T, Cance WG: Molecular mechanisms involved in tumorisenesis and their surgical implications. Am J Surg 167:428, 1994
20. Partridge M, Kiguwa S, Langdon JD: Frequent deletion of chromosome 3p in oral squamous cell carcinoma. Oral Oncol Eur J Cancer 30:248, 1994
21. Spandidos DA, Lamothe A, Field JK: Multiple transcriptional activation of cellular oncogenes in human head and neck solid tumors. Anticancer Res 5:221, 1985
22. Aaronson SA: Growth factors and cancer. Science 254:1146, 1991
23. Issing WJ, Wustrow TPU, Heppt WJ: Oncogenes related to head and neck cancer. Anticancer Res 13:2541, 1993
24. Sporn MB, Roberts AB: The transforming growth factor-betas: Past, present, and future, in Piez KA, Sporn MB (eds): Transforming Growth Factor-βs: Chemistry, Biology, and Therapeutics. New York, NY, The New York Academy of Science, 1990, pp 1-6
25. Pardee AB: G1 entry and regulation of cell proliferation. Science 246:603, 1989
26. Cross M, Dexter TM: Growth factors in development, transformation, and tumorigenesis. Cell 64 271, 1991
27. Todd R, Chou MY, Matossian K, et al: Cellular sources of transforming growth factor-alpha in human oral cancer. J Dent Res 70:917, 1991
28. Wong DTW. TGF-α and oral carcinogenesis. Eur J Cancer 29B:3, 1993
29. Wong DTW, Gallagher GT, Gertz R, et al: Transforming growth factor-α in chemically transformed hamster oral keratinocytes. Cancer Res 48:3130, 1988
30. Wong DT, Weller PF, Galli SJ, et al: Human eosinophils express transforming growth factor alpha. J Exp Med 172:673, 1990
31. Todd R, Donoff BR, Gertz R, et al: TGF-alpha and EGF-receptor mRNAs in human oral cancers. Carcinogenesis 10:1553, 1989
32. Derynck R: The physiology of transforming growth factor-alpha. Adv Cancer Res 58:27, 1992
33. Grandis JR, Tweardy DJ: Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 53:3579, 1993
34. Schantz SP: Basic science advances in head and neck oncology: The past decade. Semin Surg Oncol 11:272, 1995
35. Hunter T: Cooperation between oncogenes. Cell 64:249, 1991
36. Cantley LC, Auger KR, Carpenter C, et al: Oncogenes and signal transduction. Cell 64:281, 1991
37. Bergler W, Bier H, Ganzer U: The expression of epidermal growth factor receptors in the oral mucosa of patients with oral cancer. Arch Otorhinolaryngol 246:121, 1989
38. Grandis JR, Tweardy DJ: TGF-alpha and EGFR in head and neck cancer. J Cell Biol 17:188, 1993
39. Shin DM, Ro JY, Hong WK, et al: Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorignesis. Cancer Res 53:3153, 1994
40. Christensen ME, Therkildsen MH, Hansen BL, et al: Epidermal growth factor receptor expression on oral mucosa dysplastic epithelia and squamous cell carcinomas. Eur Arch Otorhinolaryngol 249:4905, 1992
41. Santini J, Formento JL, Francoual M, et al: Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas. Head Neck 13:132, 1991
42. Bos JL: ras oncogenes in human cancer: A review. Cancer Res 49:4682, 1989
43. Barbacid M: ras genes. Annu Rev Biochem 56:779, 1987
44. Lachman DS. Transcription-factor mutations and disease. N Engl J Med 334:28, 1996
45. Callender T, El-Nagger AK, Lee MS, et al: PRAD-1 (CCND1)/ cyclin D1 oncogene amplification in primary head and neck squamous cell carinoma. Cancer 74:152, 1994
46. Knudson AG: Genetics and the etiology of human cancer. Adv Hum Genet 8:1, 1977
47. Knudson AG: Hereditary cancer, oncogenes, and anti-oncogenes. Cancer Res 45:1437, 1985
48. Knudson AG: Antioncogenes and human cancer Proc Natl Acad Sci 90:10914, 1993
49. Stanbridge EJ: Specific chromosomal loss associated with the expression of tumorigenicity in human cell hybrids. Somatic Cell Mol Genet 7:699, 1981
50. Stanbridge EJ: Human cell hybrids. Analysis of transformation and tumorigenicity. Science 215:252, 1982
51. Stanbridge EJ: A genetic basis for tumour suppression. Ciba Found Symp 142:149, 1989
52. Moroco JR, Solt DB, Polverini PJ: Sequential loss of suppressor genes for three specific functions during in vivo carcinogenesis. Lab Invest 63:298, 1990
53. Bookstein R, Lee WH: Molecular genetics of the retinoblastoma suppressor gene. Crit Rev Oncol 2:211, 1991
54. Lui TJ, Zhang WW, Taylor DI, et al: Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Cancer Res 54:3662, 1994
55. Todd R, McBride J, Tsuji T, et al: Deleted in oral cancer-1 (doc-1), a novel oral tumor suppressor gene. FASEB J 9:1362, 1995
56. Hollstein M, Sidransky D, Vogelstein B, et al: p53 mutations in human cancers. Science 253:49, 1991
57. Hartwell LH, Kastan MB: Cell cycle control and cancer. Science 266:1821, 1994
58. Sidransky D, Boyle J, Koch W: Molecular screening: Prospects for a new approach. Arch Otolaryngol Head Neck Surg 119:1187, 1993
59. Gordon HM, Kucera G, Salvo R, et al: Tumor necrosis factor induces genes involved in inflammation, cellular and tissue repair, and metabolism in murine fibroblasts. J Immunol 148:4021, 1992
60. Pillai S, Bikle D, Eessalu T, et al: Binding and biological effects of tumor necrosis factor alpha on cultured human neonatal foreskin keratinocytes. J Clin Invest 83.816, 1989
61. Sacchi M, Kaplan I, Johnson JT, et al: Antiproliferative effects of cytokines on squamous cell carcinoma Arch Otolaryngol Head Neck Surg 117:321, 1991
62. Yasumura L, Hirabayashi H, Schwartz DR, et al: Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck. Cancer Res 53:1461, 1993
63. Howe PH, Draetta G, Leof EB. Transforming growth factor β-1 inhibition of p34 phosporylation and histone H1 kinase activity is associated with G1/S-phase growth arrest. Mol Cell Biol 11:1185, 1991
64. Moses JL, Yang EY, Pietenpol JA: TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights. Cell 63:245, 1990
65. Irish JC: Oncogenes, molecular biology and the head and neck surgeon. J Otolaryngol 21:1, 1992
66. Behrens J, Mareel MM, VanRoy FM, et al: Epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol 113:173, 1898
67. Kim MS, Li S-L, Bertolami CN, et al: State of p53, Rb, and DCC tumor suppressor genes in human oral cancer cell lines. Anticancer Res 13:1405, 1993
68. Polverini PJ: The pathophysiology of angiogenesis. Crit Rev Oral Biol Med 6:230, 1995
69. Largey JS, Meltzer SJ, Sauk JJ, et al: Loss of heterozygosity involving the APC gene in squamous cell carcinomas. Oral Surg Oral Med Oral Pathol 77:260, 1994
70. Lotan R, Xu XC, Lippman SM, et al: Suppression of retinoic acied receptor-beta in premalignant oral lesions and its upregulation by isoretinoin. N Engl J Med 332:1405, 1995
71. DeLuca LM: Retinoids and their receptors in differentiation, embryogenesis, and neoplasia. FASEB J 5:2924, 1991
72. Nawroz H, van der Riet P, Hruban RH, et al: Allelotype of head and neck squamous cell carcinoma. Cancer Res 54:1152, 1994
73. Ahsee KW, Cooke TG, Pickford IR, et al: An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res 54:1617, 1994
74. van der Riet P, Nawroz H, Hruban RH, et al. Frequent loss of chomosome 9p21-22 early in head and neck cancer progression. Cancer Res 54:1156, 1994
75. Serrano M, Hannon GJ: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704, 1993
76. Kamb A, Gruis NA, Weaverfeldhaus J, et al: A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436, 1994
77. Korf B: Molecular diagnosis. N Engl J Med 332:1218, 1995
78. Naber SP: Molecular pathology: Detection of neoplasia. N Engl J Med 331:1508, 1994
79. Brenner SE, Lippman SM, Hong WK: Prevention of second head and neck cancers. Semin Radiat Oncol 2:206, 1992
80. Roth JA: Molecular surgery for cancer. Arch Surg 127:129, 1992
81. Riviere A, Wickens C, Loning T: Expression of c-erb-B-2 and c-myc in squamous epithelia and squamous cell carcinomas of the head and neck and the lower female genital tract. J Oral Pathol Med 19:408, 1990
82. Natt E, Magenis RE, Zimmer J, et al: Regional assignment of the human loci for uvomorulin (UVO) and chymotrypsynogen B (CRTB) with the help of two overlapping deletions on the long arm of chromosome 16. Cytogenet Cell Genet 50:145, 1989
83. Cowan JM, Beckett MA, Wichselboum RR: Chromosome changes characterizing in vitro response to radiation in human squamous cell cardinoma lines. Cancer Res 53:5542, 1993
84. O'Malley BW, Ledley FD: Somatic gene therapy in otolaryngology-head and neck surgery. Arch Otolaryngol Head Neck Surg 119:1191, 1993
85. Feigner PL, Rhodes G: Gene therapeutics. Nature 349:351, 1991
86. Rosenberg SA: Immunotherapy and gene therapy of cancer. Cancer Res 51:5074, 1991
87. Miller AD: Human gene therapy comes of age. Nature 357:455, 1992
88. Debs RJ, Fuchs HJ, Philip R: Immunomodulatory and toxic effects of free and liposome-encapulated tumor necrosis factor alpha in rats. Cancer Res 50:375, 1990
89. Paoletti C: Anti-sense oligonucleotides as potential antitumor agents: Prospective views and preliminary results. Anticancer Drug Res 2:325, 1988
90. Wagner RW Gene inhibition using antisense oligodeoxynucleotides. Nature 372:333, 1994
91. Pastan I, Fitxgerald D: Recombinant toxins for cancer treatment. Science 254:1173, 1991
92. Friedman T: Gene therapy of cancer through restoration of tumor suppressor functions. Cancer 70:1810, 1992
93. O'Reilly MS, Holmgren L, Shing Y, et al: Antiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79:315, 1994
94. Avalosse B, Dupont F, Burny A: Gene therapy for cancer. Cur Opin Oncol 7:94, 1995
95. Lyerly HK, DiMaio JM: Gene delivery systems in surgery. Arch Surg 128:1197, 1993
96. Shillitoe EJ, Lapeyre J-N, Adler-Storthz K: Gene therapy: Its potential in the management of oral cancer. Oral Oncol Dur J Cancer 30B:143, 1994